Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice
Inhibition from the inside Inhibiting the receptor for advanced glycation end products (RAGE) has been shown to reduce complications of diabetes. Instead of targeting the